Investors - Mendus

Investors
<picture><source type="image/webp" srcSet="/static/6d9b87783341ce51e45ef11f598677aa/83510/Investors_1-NEW-1-scaled.webp 640w,/static/6d9b87783341ce51e45ef11f598677aa/9d163/Investors_1-NEW-1-scaled.webp 1280w,/static/6d9b87783341ce51e45ef11f598677aa/ace97/Investors_1-NEW-1-scaled.webp 2560w" sizes="(min-width: 2560px) 2560px, 100vw"/><img data-gatsby-image-ssr="" data-main-image="" style="opacity:0" sizes="(min-width: 2560px) 2560px, 100vw" decoding="async" loading="lazy" src="/static/6d9b87783341ce51e45ef11f598677aa/6f033/Investors_1-NEW-1-scaled.jpg" srcSet="/static/6d9b87783341ce51e45ef11f598677aa/1b145/Investors_1-NEW-1-scaled.jpg 640w,/static/6d9b87783341ce51e45ef11f598677aa/73c00/Investors_1-NEW-1-scaled.jpg 1280w,/static/6d9b87783341ce51e45ef11f598677aa/6f033/Investors_1-NEW-1-scaled.jpg 2560w" alt=""/></picture>
Welcome to the Mendus investor page. Mendus is listed on NASDAQ Stockholm under the ticker symbol IMMU. 

Overview
Press releases
Events
Corporate Governance
Articles of Association
General meetings
Board of Directors
Corporate governance reports
Senior executives
Nomination committee
Remuneration and the remuneration committee
Auditors and audit committee
Scientific committee
Shareholder & stock info
Share monitor
Shareholders
Analyst coverage
Financial reports
Financial calendar
Transactions
Reverse share split (2024)
Rights Issue and Directed Issue (2023)
Archive
Letter from the CEO“Capturing the immunotherapy opportunity in myeloid blood cancers”
To read the latest CEO comment, please click here.
Corporate presentation Please find below the latest corporate presentation
 

Contact
Telephone+46 (0)8 732 8400
Emailinfo@mendus.com
<picture><source type="image/webp" srcSet="/static/411b7857055b0888002108e1bcc9e280/e64f1/heado.webp 100w,/static/411b7857055b0888002108e1bcc9e280/8b00d/heado.webp 200w,/static/411b7857055b0888002108e1bcc9e280/9c0a1/heado.webp 400w,/static/411b7857055b0888002108e1bcc9e280/88f3e/heado.webp 800w" sizes="(min-width: 400px) 400px, 100vw"/><img data-gatsby-image-ssr="" data-main-image="" style="opacity:0" sizes="(min-width: 400px) 400px, 100vw" decoding="async" loading="lazy" src="/static/411b7857055b0888002108e1bcc9e280/10998/heado.jpg" srcSet="/static/411b7857055b0888002108e1bcc9e280/93e3f/heado.jpg 100w,/static/411b7857055b0888002108e1bcc9e280/839ae/heado.jpg 200w,/static/411b7857055b0888002108e1bcc9e280/10998/heado.jpg 400w,/static/411b7857055b0888002108e1bcc9e280/a677a/heado.jpg 800w" alt="&lt;p&gt;Image of old buildings by a dock with boats laying in the water in the foreground.&lt;/p&gt;
"/></picture>
Head OfficeVästra Trädgårdsgatan 15

111 53 Stockholm

Sweden
<picture><source type="image/webp" srcSet="/static/99d97027eda87168e92d8d30678ace5b/e64f1/rdo.webp 100w,/static/99d97027eda87168e92d8d30678ace5b/8b00d/rdo.webp 200w,/static/99d97027eda87168e92d8d30678ace5b/9b01d/rdo.webp 400w,/static/99d97027eda87168e92d8d30678ace5b/08dc5/rdo.webp 800w" sizes="(min-width: 400px) 400px, 100vw"/><img data-gatsby-image-ssr="" data-main-image="" style="opacity:0" sizes="(min-width: 400px) 400px, 100vw" decoding="async" loading="lazy" src="/static/99d97027eda87168e92d8d30678ace5b/fa758/rdo.jpg" srcSet="/static/99d97027eda87168e92d8d30678ace5b/93e3f/rdo.jpg 100w,/static/99d97027eda87168e92d8d30678ace5b/839ae/rdo.jpg 200w,/static/99d97027eda87168e92d8d30678ace5b/fa758/rdo.jpg 400w,/static/99d97027eda87168e92d8d30678ace5b/3f065/rdo.jpg 800w" alt="&lt;p&gt;City image from a walkway, with a church and tall buildings in the background.&lt;/p&gt;
"/></picture>
R&D OfficesEmmy Noetherweg 2K 

2333 BK Leiden

The Netherlands